Literature DB >> 12200529

The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.

J Cranshaw1, M J D Griffiths, T W Evans.   

Abstract

Pharmacological approaches to the treatment of ARDS are reviewed. Future treatments should be targeted at elements of the pathological process that produce specific clinical problems.

Mesh：

Substances：

Year:  2002        PMID： 12200529      PMCID： PMC1746421          DOI： 10.1136/thorax.57.9.823

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


  72 in total

1.  Fibroproliferative phase of ARDS. Clinical findings and effects of corticosteroids.

Authors:  G U Meduri; J M Belenchia; R J Estes; R G Wunderink; M el Torky; K V Leeper
Journal:  Chest       Date:  1991-10       Impact factor: 9.410

Review 2.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

3.  UK guidelines for the use of inhaled nitric oxide therapy in adult ICUs. American-European Consensus Conference on ALI/ARDS.

Authors:  B H Cuthbertson; P Dellinger; O J Dyar; T E Evans; T Higenbottam; R Latimer; D Payen; S A Stott; N R Webster; J D Young
Journal:  Intensive Care Med       Date:  1997-12       Impact factor: 17.440

4.  Effects of prostaglandin E1 on oxygen delivery and consumption in patients with the adult respiratory distress syndrome. Results from the prostaglandin E1 multicenter trial. The Prostaglandin E1 Study Group.

Authors:  H J Silverman; G Slotman; R C Bone; R Maunder; T M Hyers; M D Kerstein; J J Ursprung
Journal:  Chest       Date:  1990-08       Impact factor: 9.410

5.  Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome.

Authors:  H Gerlach; R Rossaint; D Pappert; K J Falke
Journal:  Eur J Clin Invest       Date:  1993-08       Impact factor: 4.686

6.  Treatment with N-acetylcysteine during acute respiratory distress syndrome: a randomized, double-blind, placebo-controlled clinical study.

Authors:  G Domenighetti; P M Suter; M D Schaller; R Ritz; C Perret
Journal:  J Crit Care       Date:  1997-12       Impact factor: 3.425

7.  Corticosteroid rescue treatment of progressive fibroproliferation in late ARDS. Patterns of response and predictors of outcome.

Authors:  G U Meduri; A J Chinn; K V Leeper; R G Wunderink; E Tolley; H T Winer-Muram; V Khare; M Eltorky
Journal:  Chest       Date:  1994-05       Impact factor: 9.410

8.  Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

Authors:  R V McCloskey; R C Straube; C Sanders; S M Smith; C R Smith
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

9.  Reduced mortality in association with the acute respiratory distress syndrome (ARDS).

Authors:  S J Abel; S J Finney; S J Brett; B F Keogh; C J Morgan; T W Evans
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

10.  Direct comparison of inhaled nitric oxide and aerosolized prostacyclin in acute respiratory distress syndrome.

Authors:  D Walmrath; T Schneider; R Schermuly; H Olschewski; F Grimminger; W Seeger
Journal:  Am J Respir Crit Care Med       Date:  1996-03       Impact factor: 21.405
View more
  6 in total

1.  The pulmonary physician in critical care * Illustrative case 6: Acute chest syndrome of sickle cell anaemia.

Authors:  V Mak; S C Davies
Journal:  Thorax       Date:  2003-08       Impact factor: 9.139

Review 2.  Effect of nitric oxide on oxygenation and mortality in acute lung injury: systematic review and meta-analysis.

Authors:  Neill K J Adhikari; Karen E A Burns; Jan O Friedrich; John T Granton; Deborah J Cook; Maureen O Meade
Journal:  BMJ       Date:  2007-03-23

Review 3.  Acute lung injury and acute respiratory distress syndrome.

Authors:  Anil Vasudevan; Rakesh Lodha; S K Kabra
Journal:  Indian J Pediatr       Date:  2004-08       Impact factor: 1.967

Review 4.  Prone position for acute respiratory failure in adults.

Authors:  Roxanna Bloomfield; David W Noble; Alexis Sudlow
Journal:  Cochrane Database Syst Rev       Date:  2015-11-13

Review 5.  Exogenous pulmonary surfactant for the treatment of adult patients with acute respiratory distress syndrome: results of a meta-analysis.

Authors:  Warren J Davidson; Del Dorscheid; Roger Spragg; Michael Schulzer; Edwin Mak; Najib T Ayas
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

6.  Endothelin antagonists: new bullets against lung injury?

Authors:  Marc Leeman
Journal:  Crit Care       Date:  2005-04-14       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.